Perspectives of farmers and tourists on agricultural abandonment in east Lesvos, Greece.

Perspectives of farmers and tourists on agricultural abandonment in east Lesvos, Greece.

Multi-stakeholder perceptions of panorama modifications are more and more acknowledged as important inputs to discussions on future panorama developments, significantly when addressing the way forward for European rural areas experiencing agricultural abandonment.

This analysis presents a case exploration of abandonment of olive plantations in east Lesvos, Greece. We carried out two units of semi-structured interviews to narrate an exploration on native farmers’ capacity and willingness to keep up the plantations, to the outcomes of a panorama choice survey undertaken with vacationers. Three farmer varieties are recognized following a cluster evaluation based mostly on attributes of particular person capacity and willingness to farm. Farmers belonging to the prevalent kind revealed low capacity and willingness and count on to additional extensify their farms.

The remaining two farmer varieties have greater willingness; they’re motivated by cultural causes, extra incessantly expressing a want to keep up their land underneath household possession, and partake in social cooperative initiatives selling practices valorizing the olive plantations. We define how these varieties work together with regional drivers of change, and partly additionally contribute to persistence of abandonment by way of constrained capacity to farm.

Abandonment doesn’t align with present panorama preferences of vacationers, who favor cultivated landscapes, components of traditionality inside constructed infrastructure and undertake nature-based actions. We focus on how excessive willingness to farm related to skilled and pluri-active types of farming could nevertheless present alternatives to keep up the cultivated panorama and synergize with (agri-)tourism demand. Our findings are corresponding to these of different European research, contributing to discussions on the way forward for its rural landscapes.

Perspectives of farmers and tourists on agricultural abandonment in east Lesvos, Greece.
Views of farmers and vacationers on agricultural abandonment in east Lesvos, Greece.

Immunophenotypic characterization, multi-lineage differentiation and growing older of zebrafish coronary heart and liver tissue-derived mesenchymal stem cells as a novel strategy in stem cell-based remedy.

Mesenchymal stem cells (MSCs) are a very good mannequin for preclinical and scientific investigations, and various sources of MSCs are topic to intensive experiments. On this examine, mesenchymal stem cells (MSCs) have been remoted from coronary heart and liver tissue of Zebrafish (Danio rerio). The flow-cytometry in addition to RT-PCR have been used to investigate the expression of a panel of cell floor markers CD44, CD90, CD31 and CD34.

Rapid antibody fluorescent labeling kit (eFluor 405)

EGQ0042 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 488)

EGQ0043 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 555)

EGQ0044 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 594)

EGQ0045 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 647)

EGQ0046 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 680)

EGQ0047 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 750)

EGQ0048 1 labeing(100ug/T)
EUR 225

Rapid antibody fluorescent labeling kit (eFluor 350)

MBS8584932-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 350)

MBS8584932-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 405)

MBS8584940-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 405)

MBS8584940-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 488)

MBS8584941-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 488)

MBS8584941-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 555)

MBS8584942-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 555)

MBS8584942-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 594)

MBS8584943-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 594)

MBS8584943-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 647)

MBS8584944-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 647)

MBS8584944-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 680)

MBS8584945-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 680)

MBS8584945-5x01mg 5x0.1mg
EUR 1480

Rapid antibody fluorescent labeling kit (eFluor 750)

MBS8584946-01mg 0.1mg
EUR 305

Rapid antibody fluorescent labeling kit (eFluor 750)

MBS8584946-5x01mg 5x0.1mg
EUR 1480

Eflucimibe

HY-19286 Get quote Ask for price
Description: Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis[1].

Eflucimibe

MBS5776963-5mg 5(mg
EUR 915

Eflucimibe

MBS5776963-5x5mg 5x5(mg
EUR 3970

Eflucimibe

T27245-10mg 10mg Ask for price
Description: Eflucimibe

Eflucimibe

T27245-1g 1g Ask for price
Description: Eflucimibe

Eflucimibe

T27245-1mg 1mg Ask for price
Description: Eflucimibe

Eflucimibe

T27245-50mg 50mg Ask for price
Description: Eflucimibe

Eflucimibe

T27245-5mg 5mg Ask for price
Description: Eflucimibe

EF1α-Luc-RFP-BSD

LFV-0001-10 2x10^6
EUR 595
Description: Blasticidin

EF1α-Luc-P2A-GFP

LFV-0001-13 2x10^6
EUR 595
Description: N/A

EF1α-Luc-P2A-RFP

LFV-0001-14 2x10^6
EUR 595
Description: N/A

EF1α-Luc-GFP-Puro

LFV-0001-09 2x10^6
EUR 595
Description: Puromycin

Anti-TSLP Monoclonal antibody, clone 2B7 [PerCP-eFluor® 710]

CABT-BL8411 100 tests
EUR 1039.5
Description: Mouse

Paritaprevir(ABT-450)

20-abx184297
  • Ask for price
  • Ask for price
  • 5 mg
  • 10 mg

Paritaprevir (ABT-450)

MBS3842435-100mg 100mg
EUR 1300

Paritaprevir (ABT-450)

MBS3842435-10mg 10mg
EUR 290

Paritaprevir (ABT-450)

MBS3842435-50mg 50mg
EUR 725

Paritaprevir (ABT-450)

MBS3842435-5mg 5mg
EUR 230

Paritaprevir (ABT-450)

MBS3842435-5x100mg 5x100mg
EUR 5850

CytoCalcein Violet 450

MBS5796932-1mg 1(mg
EUR 350

CytoCalcein Violet 450

MBS5796932-5x1mg 5x1(mg
EUR 1420

L-779, 450

MBS576191-10mg 10mg
EUR 200

L-779, 450

MBS576191-25mg 25mg
EUR 290

L-779, 450

MBS576191-2mg 2mg
EUR 155

L-779, 450

MBS576191-50mg 50mg
EUR 420

L-779, 450

MBS576191-5mg 5mg
EUR 165

Viability Dye 450

MBS697177-100Tests 100Tests
EUR 165

Viability Dye 450

MBS697177-500Tests 500Tests
EUR 335

Viability Dye 450

MBS697177-5x500Tests 5x500Tests
EUR 1455

mFluorâ„¢ Violet 450 maleimide

1600 1 mg
EUR 227
Description: AAT Bioquest\'s mFluorâ„¢ dyes are developed for multicolor flow cytometry-focused applications.

mFluorâ„¢ Violet 450 maleimide

1600-1mg 1 mg
EUR 222
Description: AAT Bioquest\'s mFluorâ„¢ dyes are developed for multicolor flow cytometry-focused applications.

mFluorâ„¢ Violet 450 Azide

1690 1 mg
EUR 315
Description: AAT Bioquest's mFluorâ„¢ dyes are developed for multicolor flow cytometry-focused applications.

mFluorâ„¢ Violet 450 Azide

1690-1mg 1 mg
EUR 308
Description: AAT Bioquest's mFluorâ„¢ dyes are developed for multicolor flow cytometry-focused applications.

mFluorâ„¢ Violet 450 SE

1150-1mg 1 mg
EUR 222
Description: AAT Bioquest's mFluor™ dyes are developed for multicolor flow cytometry-focused applications.

mFluorâ„¢ Violet 450 acid

1140 5 mg
EUR 227
Description: AAT Bioquest's mFluorâ„¢ dyes are developed for multicolor flow cytometry-focused applications.

mFluorâ„¢ Violet 450 acid

1140-5mg 5 mg
EUR 222
Description: AAT Bioquest's mFluorâ„¢ dyes are developed for multicolor flow cytometry-focused applications.

AKT1 (Ab-450) Antibody

21502 100ul
EUR 319

AKT1 (Ab-450) Antibody

21502-100ul 100ul
EUR 302.4

AKT1 (Ab-450) Antibody

21502-50ul 50ul
EUR 224.4

Akt (Ab-450) Antibody

8B0406 50ug
EUR 368
Description: Akt (Ab-450) Antibody

CF®450 Maleimide

96012 1UMOL
EUR 348
Description: N/A

CF®450 Maleimide

96012-1 EA
EUR 348

AKT1 (Ab-450) Antibody

MBS7132608-01mL 0.1mL
EUR 270

AKT1 (Ab-450) Antibody

MBS7132608-5x01mL 5x0.1mL
EUR 1200

iFluor® 450 maleimide

1057 1 mg
EUR 227
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

iFluor® 450 maleimide

1057-1mg 1 mg
EUR 222
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

Visfatin (400-450) (Human)

003-84 100 μg
EUR 355.32

Akt (Ab-450) Antibody

E11-0406B 100μg
EUR 225
Description: Available in various conjugation types.

AKT1 (Ab-450) Antibody

E021502-1 50μg/50μl
EUR 100
Description: Available in various conjugation types.

AKT1 (Ab-450) Antibody

E021502-2 100μg/100μl
EUR 170
Description: Available in various conjugation types.

anti-AKT1 (Ab-450)

LF-PA20679 100 ul
EUR 400.8
Description: Rabbit polyclonal to AKT1

Dri-Dye 450 nm

DD-2 1 unit
EUR 93
Description: Check Strips for any EIA analyzers. For 450 nm

AKT1 (Ab-450) Antibody

CSB-PA969941- each
EUR 402
Description: A polyclonal antibody against AKT1 (Ab-450). Recognizes AKT1 (Ab-450) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

AKT1 (Ab-450) Antibody

CSB-PA969941-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against AKT1 (Ab-450). Recognizes AKT1 (Ab-450) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200

AKT1 (Ab-450) Antibody

MBS857698-005mg 0.05mg
EUR 190

AKT1 (Ab-450) Antibody

MBS857698-01mg 0.1mg
EUR 255

AKT1 (Ab-450) Antibody

MBS857698-01mLAF405M 0.1mL(AF405M)
EUR 465

AKT1 (Ab-450) Antibody

MBS857698-01mLAF546 0.1mL(AF546)
EUR 465

AKT1 (Ab-450) Antibody

MBS857698-01mLAF750 0.1mL(AF750)
EUR 465

Akt (Ab-450) Antibody

MBS853607-01mg 0.1mg
EUR 305

Akt (Ab-450) Antibody

MBS853607-01mLAF405L 0.1mL(AF405L)
EUR 465

Akt (Ab-450) Antibody

MBS853607-01mLAF405S 0.1mL(AF405S)
EUR 465

Akt (Ab-450) Antibody

MBS853607-01mLAF610 0.1mL(AF610)
EUR 465

Akt (Ab-450) Antibody

MBS853607-01mLAF635 0.1mL(AF635)
EUR 465

AKT1 (Ab-450) Antibody

MBS9401940-005mL 0.05mL
EUR 245

AKT1 (Ab-450) Antibody

MBS9401940-01mL 0.1mL
EUR 305

AKT1 (Ab-450) Antibody

MBS9401940-5x01mL 5x0.1mL
EUR 1230

CytoCalcein™ Violet 450

T35611-10mg 10mg Ask for price
Description: CytoCalcein™ Violet 450

CytoCalcein™ Violet 450

T35611-1g 1g Ask for price
Description: CytoCalcein™ Violet 450

CytoCalcein™ Violet 450

T35611-1mg 1mg Ask for price
Description: CytoCalcein™ Violet 450

CytoCalcein™ Violet 450

T35611-50mg 50mg Ask for price
Description: CytoCalcein™ Violet 450

CytoCalcein™ Violet 450

T35611-5mg 5mg Ask for price
Description: CytoCalcein™ Violet 450

TubeSpin Bioreactor 450 (32)

TP87450 each Ask for price

Nhe I unit: 450

YRNHE1 1 vial Ask for price

mFluorâ„¢ Violet 450-VAD-FMK

13475-25Tests 25 Tests
EUR 109
Description: FAM-VAD is a blue fluorescent cell-permeable polycaspase inhibitor to target caspases 1, 2, 3, 6, 8, 9, or 10.

mFluorâ„¢ Violet 450-streptavidin conjugate

16930 100 ug
EUR 112
Description: Streptavidin conjugates are widely used together with a conjugate of biotin for specific detection of a variety of proteins, protein motifs, nucleic acids and other molecules since streptavidin has a very high binding affinity for biotin.

mFluorâ„¢ Violet 450-streptavidin conjugate

16930-100ug 100 ug
EUR 109
Description: Streptavidin conjugates are widely used together with a conjugate of biotin for specific detection of a variety of proteins, protein motifs, nucleic acids and other molecules since streptavidin has a very high binding affinity for biotin.

iFluor® 450 succinimidyl ester

1026-1mg 1 mg
EUR 222
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

CF®450 Succimindyl Ester

96011-1 EA
EUR 329

iFluor® 450 succinimidyl ester

71026-100ug 100 ug
EUR 82
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

iFluor® 450 succinimidyl ester

71506 5 mg
EUR 797
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

iFluor® 450 succinimidyl ester

71506-5mg 5 mg
EUR 781
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

iFluor® 450 succinimidyl ester

71556 10 mg
EUR 1328
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

iFluor® 450 succinimidyl ester

71556-10mg 10 mg
EUR 1301
Description: AAT Bioquest's iFluor® dyes are optimized for labeling proteins, particularly antibodies.

Polyclonal TLR1 Antibody (aa400-450)

APR02824G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLR1 (aa400-450). This antibody is tested and proven to work in the following applications:

Polyclonal CYP1B1 Antibody (aa400-450)

APG02857G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CYP1B1 (aa400-450). This antibody is tested and proven to work in the following applications:

Polyclonal PACSIN2 Antibody (aa400-450)

APR17733G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PACSIN2 (aa400-450). This antibody is tested and proven to work in the following applications:

Akt (Ab-450) polyclonal antibody

AP0725 50ul
EUR 275
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.

Polyclonal SNX4 Antibody (aa438-450)

AMM07924G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SNX4 (aa438-450). This antibody is tested and proven to work in the following applications:

AKT1 (Ab-450) Conjugated Antibody

C21502 100ul
EUR 476.4

Akt (Ab-450) polyclonal antibody

E43P0725 100ul
EUR 225
Description: Available in various conjugation types.

Akt(Ab-450) polyclonal antibody

E43SP1810 100ul
EUR 225
Description: Available in various conjugation types.

Visfatin (400-450) (Human) - Antibody

H-003-84 100 μl
EUR 376.92

Visfatin (400-450) (Human) - Antibody

H-003-84B 200 μl
EUR 604.8

Dok1 (Ser-450), phospho-specific

MBS472019-01mL 0.1mL
EUR 430

Dok1 (Ser-450), phospho-specific

MBS472019-5x01mL 5x0.1mL
EUR 1790

phospho-Dok1 (Ser-450) Peptide

MBS474030-005mg 0.05mg
EUR 180

phospho-Dok1 (Ser-450) Peptide

MBS474030-5x005mg 5x0.05mg
EUR 665
  1. Within the following, alizarin pink, oil red-O and toluidine blue staining have been carried out to judge the multi-lineage differentiation of zebrafish coronary heart and liver tissue-derived MSCs. Subsequently, the gene and protein expression of Oct4, Sox2 and Nanog as pluri

    -potent markers have been analyzed by RT-PCR and western blotting, respectively.

As well as, MTT assay was used for cell proliferation potential and inhabitants doubling time (PDT) evaluation. Additionally, the growing older of cells was investigated by β-galactosidase exercise assay. The outcomes confirmed that, like different MSCs, zebrafish coronary heart and liver tissue-derived MSCs have been constructive for mesenchymal, adverse for hematopoietic markers and expressed pluripotent markers Oct4, Sox2 and Nanog. Furthermore, these cells have been differentiated to osteocyte, adipocyte, and chondrocyte lineages following directed differentiation. It was discovered that PDT of zebrafish coronary heart and liver tissue-derived MSCs have been 50.67 and 46.61 h, respectively.

These cells had considerably extra speedy progress on day 4. Our outcomes present that zebrafish coronary heart and liver tissue-derived MSCs exhibited typical MSC traits together with fibroblast morphology, multi-lineage differentiation capability, pluriefficiency potential and expression of a typical set of basic MSC floor markers.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.

Platinum-based chemotherapy is the mainstay of front-line therapy of sufferers affected by pluri-metastatic intermediate/excessive grade NeuroEndocrine Neoplasms (NENs). Nevertheless, there aren’t any commonplace second-line remedies at illness development.

Earlier scientific experiences have evidenced that temozolomide (TMZ), an oral analog of dacarbazine, is lively in opposition to NENs at commonplace doses of 150 to 200 mg/mq per day on days 1 to five of a 28-day cycle, even when a major treatment-related toxicity is reported.

METHODS

Metastatic NENs sufferers had been handled on the ENETS (European NeuroEndocrine Tumor Society) heart of excellence of Naples (Italy), from 2014 to 2017 with a second-line various metronomic schedule of TMZ, 75 mg/m2per os “one week on/one week off”. Toxicity was graded with NCI-CTC standards v4.0; goal responses with RECIST v1.1 and efficiency standing (PS) in accordance with ECOG.

Twenty-six consecutive sufferers had been handled. Median age was 65.5 years. The predominant main organs had been pancreas and lung. Grading was G2 in 11 sufferers, G3 in 15. Greater than half of sufferers had a PS 2 (15 vs. 11 with PS 1). The median time-on-temozolomide remedy was 12.2 months (95% CI: 11.4-19.6). No G3/G4 toxicities had been registered.

Full response was obtained in 1 affected person, partial response in 4, steady illness in 19 (illness management price: 92.3%), and progressive illness in 2. The median total survival from TMZ begin was 28.Three months. PS improved in 73% of sufferers.Metronomic TMZ is an acceptable therapy for G2 and G3 NENs significantly in PS 2 sufferers. Potential and bigger trials are wanted to verify these outcomes.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.
Security and Exercise of Metronomic Temozolomide in Second-Line Remedy of Superior Neuroendocrine Neoplasms.

Would ivermectin for malaria management be useful in onchocerciasis-endemic areas?

There may be accumulating proof supporting using ivermectin as a malaria management software. Latest findings from the repeat ivermectin mass drug administrations for management of malaria trial demonstrated a diminished incidence of malaria in villages which obtained repeated ivermectin mass drug administration (MDA; six doses) in comparison with those that had just one spherical of ivermectin.

EEF1A2

MBS9125428-01mL 0.1mL
EUR 345

EEF1A2

MBS9125428-02mL 0.2mL
EUR 545

EEF1A2

MBS9125428-5x02mL 5x0.2mL
EUR 2265

EEF1A2

MBS8563645-01mLAF405L 0.1mL(AF405L)
EUR 565

EEF1A2

MBS8563645-01mLAF405S 0.1mL(AF405S)
EUR 565

EEF1A2

MBS8563645-01mLAF610 0.1mL(AF610)
EUR 565

EEF1A2

MBS8563645-01mLAF635 0.1mL(AF635)
EUR 565

EEF1A2

MBS8563645-02mL 0.2mL
EUR 345

EEF1A2 Peptide

43-205P 0.1 mg
EUR 405.6

EEF1A2 Antibody

MBS7044431-005mL 0.05mL
EUR 190

EEF1A2 Antibody

MBS7044431-01mL 0.1mL
EUR 270

EEF1A2 Antibody

MBS7044431-5x01mL 5x0.1mL
EUR 1205

EEF1A2 Antibody

MBS7044252-005mL 0.05mL
EUR 190

EEF1A2 Antibody

MBS7044252-01mL 0.1mL
EUR 270

EEF1A2 Antibody

MBS7044252-5x01mL 5x0.1mL
EUR 1205

EEF1A2 Antibody

45965-100ul 100ul
EUR 302.4

EEF1A2 Antibody

45965-50ul 50ul
EUR 224.4

EEF1A2 antibody

70R-3046 50 ug
EUR 467
Description: Rabbit polyclonal EEF1A2 antibody raised against the middle region of EEF1A2

EEF1A2 Antibody

E19-9493-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

EEF1A2 Antibody

E19-9493-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

EEF1A2 antibody

70R-17001 50 ul
EUR 289
Description: Rabbit polyclonal EEF1A2 antibody

EEF1A2 Antibody

ABD9493 100 ug
EUR 525.6

EEF1A2 Antibody

AF6618 100ul
EUR 420

EEF1A2 Antibody

AF6618-100ul 100ul
EUR 168
Description: ELISA(peptide)

EEF1A2 Antibody

AF6618-200ul 200ul
EUR 210
Description: ELISA(peptide)

EEF1A2 Antibody

DF9493 200ul
EUR 420

EEF1A2 Antibody

DF9493-100ul 100ul
EUR 168
Description: WB,IF/ICC,ELISA(peptide)

EEF1A2 Antibody

DF9493-200ul 200ul
EUR 210
Description: WB,IF/ICC,ELISA(peptide)

EEF1A2 Antibody

1-CSB-PA007412ESR1HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against EEF1A2. Recognizes EEF1A2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

EEF1A2 Antibody

1-CSB-PA007412ESR2HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against EEF1A2. Recognizes EEF1A2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

EEF1A2 Antibody

1-CSB-PA007412GA01HU
  • Ask for price
  • Ask for price
  • 50ul
  • 150ul
Description: A polyclonal antibody against EEF1A2. Recognizes EEF1A2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

EEF1A2 Antibody

GWB-MR059E 50ug Ask for price

EEF1A2 Antibody

E311602 200ul
EUR 275
Description: Available in various conjugation types.

EEF1A2 antibody

E39-10409 100ug/100ul
EUR 225
Description: Available in various conjugation types.

eEF1A2 Antibody

E92473 100ul
EUR 255
Description: Available in various conjugation types.

eEF1A2 Antibody

MBS8504964-01mL 0.1mL
EUR 325

eEF1A2 Antibody

MBS8504964-01mLAF405L 0.1mL(AF405L)
EUR 565

eEF1A2 Antibody

MBS8504964-01mLAF405S 0.1mL(AF405S)
EUR 565

eEF1A2 Antibody

MBS8504964-01mLAF610 0.1mL(AF610)
EUR 565

eEF1A2 Antibody

MBS8504964-01mLAF635 0.1mL(AF635)
EUR 565

EEF1A2 Antibody

MBS8518504-005mg 0.05mg
EUR 235

EEF1A2 Antibody

MBS8518504-01mg 0.1mg
EUR 305

EEF1A2 Antibody

MBS8518504-01mLAF405M 0.1mL(AF405M)
EUR 465

EEF1A2 Antibody

MBS8518504-01mLAF546 0.1mL(AF546)
EUR 465

EEF1A2 Antibody

MBS8518504-01mLAF750 0.1mL(AF750)
EUR 465

EEF1A2 Antibody

MBS9609810-01mL 0.1mL
EUR 260

EEF1A2 Antibody

MBS9609810-02mL 0.2mL
EUR 305

EEF1A2 Antibody

MBS9609810-5x02mL 5x0.2mL
EUR 1220

EEF1A2 Antibody

MBS9613639-01mL 0.1mL
EUR 260

EEF1A2 Antibody

MBS9613639-02mL 0.2mL
EUR 305

EEF1A2 Antibody

MBS9613639-5x02mL 5x0.2mL
EUR 1220

EEF1A1 / EEF1A2 / EEF1A1P5 Antibody

abx327705-100g 100 µg
EUR 250

EEF1A1 / EEF1A2 / EEF1A1P5 Antibody

20-abx327705
  • Ask for price
  • Ask for price
  • 50 ug
  • 100 ug

EEF1A1 / EEF1A2 / EEF1A1P5 Antibody

abx327705-50g 50 µg
EUR 187.5

EEF1A1/EEF1A2/EEF1A1P5 Antibody

MBS7117700-005mg 0.05mg
EUR 150

EEF1A1/EEF1A2/EEF1A1P5 Antibody

MBS7117700-01mg 0.1mg
EUR 190

EEF1A1/EEF1A2/EEF1A1P5 Antibody

MBS7117700-5x01mg 5x0.1mg
EUR 845

EEF1A1/EEF1A2/EEF1A1P5 Antibody

1-CSB-PA005918
  • Ask for price
  • Ask for price
  • 50ug
  • 100ug
Description: A polyclonal antibody against EEF1A1/EEF1A2/EEF1A1P5. Recognizes EEF1A1/EEF1A2/EEF1A1P5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

Rat EEF1A2 siRNA

20-abx914976
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

EEF1A2 siRNA (Rat)

MBS827163-15nmol 15nmol
EUR 405

EEF1A2 siRNA (Rat)

MBS827163-30nmol 30nmol
EUR 565

EEF1A2 siRNA (Rat)

MBS827163-5x30nmol 5x30nmol
EUR 2450

EEF1A2 Rabbit pAb

A2473 1000μL
EUR 88.56

EEF1A2 Rabbit pAb

A2473-100ul 100 ul
EUR 369.6

EEF1A2 Rabbit pAb

A2473-200ul 200 ul
EUR 550.8

EEF1A2 Rabbit pAb

A2473-20ul 20 ul
EUR 219.6

EEF1A2 Rabbit pAb

A2473-50ul 50 ul
EUR 267.6

EEF1A2 Rabbit pAb

A7327 1000μL
EUR 70.85

EEF1A2 Rabbit pAb

A7327-100ul 100 ul
EUR 369.6

EEF1A2 Rabbit pAb

A7327-200ul 200 ul
EUR 550.8

EEF1A2 Rabbit pAb

A7327-20ul 20 ul
EUR 219.6

EEF1A2 Rabbit pAb

A7327-50ul 50 ul
EUR 267.6

EEF1A2 Rabbit pAb

E2502473 100ul
EUR 225
Description: Available in various conjugation types.

EEF1A2 Rabbit pAb

E2507327 100ul
EUR 225
Description: Available in various conjugation types.

EEF1A2 Rabbit pAb

E45R24777N 50 ul
EUR 297.75

EEF1A2 Rabbit pAb

E45R27295N 50 ul
EUR 297.75

EEF1A2 Rabbit mAb

MBS4753252-01mL 0.1mL
EUR 450

EEF1A2 Rabbit mAb

MBS4753252-5x01mL 5x0.1mL
EUR 1540

EEF1A2 Rabbit pAb

MBS8544928-01mL 0.1mL
EUR 305

EEF1A2 Rabbit pAb

MBS8544928-01mLAF405L 0.1mL(AF405L)
EUR 565

EEF1A2 Rabbit pAb

MBS8544928-01mLAF405S 0.1mL(AF405S)
EUR 565

EEF1A2 Rabbit pAb

MBS8544928-01mLAF610 0.1mL(AF610)
EUR 565

EEF1A2 Rabbit pAb

MBS8544928-01mLAF635 0.1mL(AF635)
EUR 565

EEF1A2 Rabbit pAb

MBS8546738-01mL 0.1mL
EUR 305

EEF1A2 Rabbit pAb

MBS8546738-01mLAF405L 0.1mL(AF405L)
EUR 565

EEF1A2 Rabbit pAb

MBS8546738-01mLAF405S 0.1mL(AF405S)
EUR 565

EEF1A2 Rabbit pAb

MBS8546738-01mLAF610 0.1mL(AF610)
EUR 565

EEF1A2 Rabbit pAb

MBS8546738-01mLAF635 0.1mL(AF635)
EUR 565

Human EEF1A2 siRNA

20-abx901643
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Mouse EEF1A2 siRNA

20-abx914977
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

EEF1A2 siRNA (Mouse)

MBS8206897-15nmol 15nmol
EUR 405

EEF1A2 siRNA (Mouse)

MBS8206897-30nmol 30nmol
EUR 565

EEF1A2 siRNA (Mouse)

MBS8206897-5x30nmol 5x30nmol
EUR 2450

EEF1A2 siRNA (Human)

MBS8202962-15nmol 15nmol
EUR 405

EEF1A2 siRNA (Human)

MBS8202962-30nmol 30nmol
EUR 565

EEF1A2 siRNA (Human)

MBS8202962-5x30nmol 5x30nmol
EUR 2450

Human EEF1a2 Protein

20-abx650911
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Human EEF1a2 Protein

abx650911-5mg 5 mg
EUR 337.5

anti- EEF1A2 antibody

FNab02642 100µg
EUR 606.3
Description: Antibody raised against EEF1A2

EEF1A2 Blocking Peptide

33R-9588 100 ug
EUR 119
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EEF1A2 antibody, catalog no. 70R-3046

EEF1A2 Blocking Peptide

DF9493-BP 1mg
EUR 234

EEF1A2 Blocking Peptide

MBS9628514-1mg 1mg
EUR 380

EEF1A2 Blocking Peptide

MBS9628514-5x1mg 5x1mg
EUR 1650

EEF1A2 Blocking Peptide

MBS9617720-1mg 1mg
EUR 380

EEF1A2 Blocking Peptide

MBS9617720-5x1mg 5x1mg
EUR 1650

Recombinant Human EEF1A2

MBS7608636-005mg 0.05mg
EUR 345

Recombinant Human EEF1A2

MBS7608636-02mg 0.2mg
EUR 635

Recombinant Human EEF1A2

MBS7608636-1mg 1mg
EUR 1800

Recombinant Human EEF1A2

MBS7608636-5x1mg 5x1mg
EUR 6955

Recombinant Human EEF1A2

P0565 100ug
EUR 626.83
Description: Recombinant Human protein for EEF1A2

EEF1A2 Immunizing Peptide

MBS427810-01mg 0.1mg
EUR 225

EEF1A2 polyclonal antibody

BS8838 50 ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

EEF1A2 Conjugated Antibody

C45965 100ul
EUR 476.4

EEF1A2 Polyclonal Antibody

E97327 100ul
EUR 225
Description: Available in various conjugation types.

EEF1A2 Polyclonal Antibody

E-AB-61648-120uL 120uL
EUR 320
Description: Unconjugated

EEF1A2 Polyclonal Antibody

E-AB-61648-200uL 200uL
EUR 530
Description: Unconjugated

EEF1A2 Polyclonal Antibody

E-AB-61648-60uL 60uL
EUR 200
Description: Unconjugated

EEF1A2 Polyclonal Antibody

E-AB-61648-each each Ask for price
Description: Unconjugated

EEF1A2 Polyclonal Antibody

MBS126428-002mL 0.02mL
EUR 200

EEF1A2 Polyclonal Antibody

MBS126428-005mL 0.05mL
EUR 255

EEF1A2 Polyclonal Antibody

MBS126428-01mL 0.1mL
EUR 345

EEF1A2 Polyclonal Antibody

MBS126428-02mL 0.2mL
EUR 545

EEF1A2 Polyclonal Antibody

MBS126428-5x02mL 5x0.2mL
EUR 2265

EEF1A2 Polyclonal Antibody

MBS2538211-006mL 0.06mL
EUR 190

EEF1A2 Polyclonal Antibody

MBS2538211-012mL 0.12mL
EUR 265

EEF1A2 Polyclonal Antibody

MBS2538211-02mL 0.2mL
EUR 415

EEF1A2 Polyclonal Antibody

MBS2538211-5x02mL 5x0.2mL
EUR 1835

Recombinant EEF1A2 protein

MBS389269-002mg 0.02mg
EUR 610

Recombinant EEF1A2 protein

MBS389269-1mg 1mg
EUR 3345

Recombinant EEF1A2 protein

MBS389269-5x1mg 5x1mg
EUR 14870

EEF1A2 Polyclonal Antibody

MBS8573337-01mL 0.1mL
EUR 305

EEF1A2 Polyclonal Antibody

MBS8573337-01mLAF405L 0.1mL(AF405L)
EUR 565

EEF1A2 Polyclonal Antibody

MBS8573337-01mLAF405S 0.1mL(AF405S)
EUR 565

EEF1A2 Polyclonal Antibody

MBS8573337-01mLAF610 0.1mL(AF610)
EUR 565

EEF1A2 Polyclonal Antibody

MBS8573337-01mLAF635 0.1mL(AF635)
EUR 565

EEF1A2 Conjugated Antibody

MBS9453917-01mLAF350 0.1mL(AF350)
EUR 480

EEF1A2 Conjugated Antibody

MBS9453917-01mLAF405 0.1mL(AF405)
EUR 480

EEF1A2 Conjugated Antibody

MBS9453917-01mLAF488 0.1mL(AF488)
EUR 480

EEF1A2 Conjugated Antibody

MBS9453917-01mLAF555 0.1mL(AF555)
EUR 480

EEF1A2 Conjugated Antibody

MBS9453917-01mLBiotin 0.1mL(Biotin)
EUR 480

EEF1A2 Polyclonal Antibody

RD82636A-120uL 120μL
EUR 360
Description: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer.

EEF1A2 Polyclonal Antibody

RD82636A-200uL 200μL
EUR 630
Description: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer.

EEF1A2 Polyclonal Antibody

RD82636A-60uL 60μL
EUR 204
Description: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer.

EEF1A2 Polyclonal Antibody

RD84423A-120uL 120μL
EUR 360
Description: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer.

EEF1A2 Polyclonal Antibody

RD84423A-200uL 200μL
EUR 630
Description: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer.

EEF1A2 Polyclonal Antibody

RD84423A-60uL 60μL
EUR 204
Description: This gene encodes an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer.

EEF1A1/ EEF1A2 Antibody (N-term)

E45R05771G-1 100 ul
EUR 395

EEF1A1/ EEF1A2 Antibody (N-term)

E45R05771G-4 50 ul
EUR 295

EEF1A2 ELISA KIT|Human

EF009296 96 Tests
EUR 826.8

Rat EEF1A2 shRNA Plasmid

20-abx984646
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

EEF1A2 Antibody (C-term)

E45R30977G-1 100 ul
EUR 395

EEF1A2 Antibody (C-term)

E45R30977G-4 50 ul
EUR 295

EEF1A2 Antibody (C-term)

MBS9208327-008mL 0.08mL
EUR 210

EEF1A2 Antibody (C-term)

MBS9208327-04mL 0.4mL
EUR 430

EEF1A2 Antibody (C-term)

MBS9208327-5x04mL 5x0.4mL
EUR 1910

A number of different research investigating the advantages of ivermectin for malaria functions are ongoing/deliberate.Whereas ivermectin MDA provides promising views within the combat in opposition to malaria, we spotlight the added advantages and anticipated challenges of conducting future research in onchocerciasis-endemic areas, that are confronted with a considerable illness burden together with onchocerciasis-associated epilepsy.

Rising the frequency of ivermectin MDA in such locations could scale back the burden of each malaria and onchocerciasis, and permit for extra entomological investigations on each the Anopheles mosquitoes and the blackflies.

Upfront, acceptability and feasibility research are wanted to evaluate the endorsement by the native populations, in addition to the programmatic feasibility of implementing ivermectin MDA a number of occasions a yr.Onchocerciasis-endemic websites would doubly profit from ivermectin MDA interventions, as these will alleviate onchocerciasis-associated morbidity and mortality, whereas doubtlessly curbing malaria transmission. Involving onchocerciasis applications and different related stakeholders within the malaria/ivermectin analysis agenda would foster the implementation of pluri-annual MDA in goal communities.

The ZT Biopolymer: A Self-Assembling Protein Scaffold for Stem Cell Applications.

The ZT Biopolymer: A Self-Assembling Protein Scaffold for Stem Cell Applications.

The event of cell tradition programs for the naturalistic propagation, self-renewal and differentiation of cells ex vivo is a excessive purpose of molecular engineering. Regardless of vital success in recent times, the excessive value of up-scaling cultures, the necessity for xeno-free tradition situations, and the diploma of mimicry of the natural extracellular matrix attainable in vitro utilizing designer substrates proceed to pose obstacles to the interpretation of cell-based technologies.

On this regard, the ZT biopolymer is a protein-based, steady, scalable, and economical cell substrate of excessive promise. ZT relies on the naturally occurring meeting of two human proteins: titin-Z1Z2 and telethonin. These protein constructing blocks are strong scaffolds that may be conveniently functionalized with full-length proteins and bioactive peptidic motifs by genetic manipulation, previous to self-assembly.

The polymer is, thereby, totally encodable. Functionalized variations of the ZT polymer have been proven to efficiently maintain the long-term culturing of human embryonic stem cells (hESCs), human induced pluripotent stem cells (hiPSCs), and murine mesenchymal stromal cells (mMSCs).

Pluripotency of hESCs and hiPSCs was retained for the longest interval assayed (four months). Outcomes level to the big potential of the ZT system for the creation of a modular, pluri-functional biomaterial for cell-based purposes.

The ZT Biopolymer: A Self-Assembling Protein Scaffold for Stem Cell Applications.

Maxwell®: An Unsupervised Studying Method for 5P Medication.

Within the 5P medication (Customized, Preventive, Participative, Predictive and Pluri-expert), the final pattern is to course of information by displacing the barycenter of the data from hospital centered programs to the affected person centered ones by his private medical information.

EGF

90201-2 500 µg_x000D_
EUR 220
Description: Human Epidermal Growth Factor (GenBank Accession No. NM_001963), a.a. 971- 1023, MW=6.2 kDa, expressed in an E. coli expression system.

EGF

90201-3 1000 µg
EUR 335
Description: Human Epidermal Growth Factor (GenBank Accession No. NM_001963), a.a. 971- 1023, MW=6.2 kDa, expressed in an E. coli expression system.

EGF

CSB-CL007473HU 10 μg plasmid + 200μl Glycerol Ask for price

EGF

GWB-21C95B 0.5 mg Ask for price

EGF

GWB-AB1AFA 1 mg Ask for price

EGF

GWB-CB9E42 0.5 mg Ask for price

EGF

E21-029 10ug
EUR 225
Description: Recombinant Human Epidermal Growth Factor is produced by our E.coli expression system and the target gene encoding Asn971-Arg1023 is expressed.

EGF

E13-007-1 10μg
EUR 25
Description: N/A

EGF

E13-007-2 50μg
EUR 50
Description: N/A

EGF

E8ET1704-33 100ul
EUR 275
Description: Available in various conjugation types.

EGF

cyt-217 100µg
EUR 60
Description: Recombinant Human Epidermal Growth Factor

EGF

LF-PR003 200 ug
EUR 170.4
Description: EGF protein

EGF

MBS516949-05mg 0.5mg
EUR 325

EGF

MBS516949-5x05mg 5x0.5mg
EUR 1205

EGF

MO15063 100 ug
EUR 490.8

EGF

MBS8532843-001mg 0.01mg
EUR 305

EGF

MBS8532843-5x001mg 5x0.01mg
EUR 1220

EGF

MBS8534534-01mL 0.1mL
EUR 345

EGF

MBS8534534-01mLAF405L 0.1mL(AF405L)
EUR 565

EGF

MBS8534534-01mLAF405S 0.1mL(AF405S)
EUR 565

EGF

MBS8534534-01mLAF610 0.1mL(AF610)
EUR 565

EGF

MBS8534534-01mLAF635 0.1mL(AF635)
EUR 565

EGF

MBS8560221-01mLAF405L 0.1mL(AF405L)
EUR 565

EGF

MBS8560221-01mLAF405S 0.1mL(AF405S)
EUR 565

EGF

MBS8560221-01mLAF610 0.1mL(AF610)
EUR 565

EGF

MBS8560221-01mLAF635 0.1mL(AF635)
EUR 565

EGF

MBS8560221-02mL 0.2mL
EUR 345

EGF

PR27006 500 ug
EUR 97.2

EGF

PR27006-B each
EUR 184.5

EGF

PR27009 500 ug
EUR 97.2

EGF

PR27009-B each
EUR 184.5

HB-EGF (Heparin Binding EGF)

MBS517060-005mg 0.05mg
EUR 240

HB-EGF (Heparin Binding EGF)

MBS517060-02mg 0.2mg
EUR 405

HB-EGF (Heparin Binding EGF)

MBS517060-1mg 1mg
EUR 1480

HB-EGF (Heparin Binding EGF)

MBS517060-5x1mg 5x1mg
EUR 6405

h. EGF

EK0325 1×96T
EUR 550
Description: ELISA

m. EGF

EK0326 1×96T
EUR 575
Description: ELISA

rHu EGF

AK8327-0100 100µg Ask for price

rHu EGF

AK8327-0500 500µg Ask for price

rHu EGF

AK8327-1000 1mg Ask for price

EGF, Rat

HY-P7092 50ug
EUR 253.2

Rat EGF

MBS691892-002mg 0.02mg
EUR 300

Rat EGF

MBS691892-01mg 0.1mg
EUR 450

Rat EGF

MBS691892-5x01mg 5x0.1mg
EUR 1725

EGF Long

cyt-798 20µg
EUR 60
Description: Recombinant Human Epidermal Growth Factor Long

EGF-816; Nazartinib

MBS130723-100mg 100mg
EUR 1065

EGF-816; Nazartinib

MBS130723-500mg 500mg
EUR 2775

Mouse EGF

90200-1 100 µg
EUR 85
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system.

Mouse EGF

90200-2 500 µg_x000D_
EUR 210
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system.

Mouse EGF

90200-3 1000 µg
EUR 320
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system.

EGF, Mouse

HY-P7067 100ug
EUR 224.4

EGF, Human

HY-P7109 50ug
EUR 129.6

EGF,Swine

E34M018S 5 μg
EUR 295

EGF,Mouse

E34M065M 100 μg
EUR 155

EGF, Human

E34M120-100HP 100 μg
EUR 155

EGF (Human)

MBS408047-01mg 0.1mg
EUR 225

EGF (Human)

MBS408047-5x01mg 5x0.1mg
EUR 955

Human EGF

MBS692154-05mg 0.5mg
EUR 305

Human EGF

MBS692154-5x05mg 5x0.5mg
EUR 1080

Human EGF

MBS691855-01mg 0.1mg
EUR 225

Human EGF

MBS691855-5x01mg 5x0.1mg
EUR 725

Mouse EGF

MBS691939-05mg 0.5mg
EUR 450

Mouse EGF

MBS691939-5x05mg 5x0.5mg
EUR 1725

Mouse EGF

MBS691993-01mg 0.1mg
EUR 300

Mouse EGF

MBS691993-5x01mg 5x0.1mg
EUR 1050

EGF, Human

MBS8575277-01mg 0.1mg
EUR 245

EGF, Human

MBS8575277-5x01mg 5x0.1mg
EUR 940

EGF, Mouse

MBS8575390-01mg 0.1mg
EUR 245

EGF, Mouse

MBS8575390-5x01mg 5x0.1mg
EUR 940

EGF, Swine

MBS8575438-0005mg 0.005mg
EUR 370

EGF, Swine

MBS8575438-5x0005mg 5x0.005mg
EUR 1520

EGF, Pichia

cyt-332 100µg
EUR 60
Description: Recombinant Human Epidermal Growth Factor, Pichia

EGF Pichia

PR27007 500 ug
EUR 97.2

EGF Pichia

PR27007-B each
EUR 184.5

EGF protein

30R-2331 500 ug
EUR 1285
Description: Purified recombinant Human EGF protein

EGF protein

30R-2332 500 ug
EUR 165
Description: Purified recombinant Mouse EGF protein

EGF protein

30R-2333 20 ug
EUR 330
Description: Purified recombinant Rat EGF protein

EGF protein

30R-1056 100 ug
EUR 102
Description: Purified recombinant Human EGF protein

EGF protein

30R-AE003 1 mg
EUR 717
Description: Purified recombinant Human EGF protein

EGF protein

30R-AE004 100 ug
EUR 312
Description: Purified recombinant Human EGF protein

EGF protein

30R-AE025 100 ug
EUR 312
Description: Purified recombinant Human EGF protein

EGF Protein

abx169012-1mg 1 mg
EUR 543.6

EGF Protein

abx069820-1g 1 g
EUR 1362.5

EGF Protein

abx069820-1mg 1 mg
EUR 1296

EGF protein

MBS538026-01mg 0.1mg
EUR 2320

EGF protein

MBS538026-05mg 0.5mg
EUR 465

EGF protein

MBS538026-5x01mg 5x0.1mg
EUR 10295

EGF protein

MBS538327-1mg 1mg
EUR 1940

EGF protein

MBS538327-5x1mg 5x1mg
EUR 8570

EGF protein

MBS536555-01mg 0.1mg
EUR 465

EGF protein

MBS536555-5x01mg 5x0.1mg
EUR 1945

EGF protein

MBS836477-01mg 0.1mg
EUR 235

EGF protein

MBS836477-5x01mg 5x0.1mg
EUR 900

EGF Antibody

MBS7113626-005mg 0.05mg
EUR 190

EGF Antibody

MBS7113626-01mg 0.1mg
EUR 270

EGF Antibody

MBS7113626-5x01mg 5x0.1mg
EUR 1205

EGF Antibody

MBS7118149-005mg 0.05mg
EUR 150

EGF Antibody

MBS7118149-01mg 0.1mg
EUR 190

EGF Antibody

MBS7118149-5x01mg 5x0.1mg
EUR 845

EGF Antibody

MBS7123634-005mL 0.05mL
EUR 190

EGF Antibody

MBS7123634-01mL 0.1mL
EUR 270

EGF Antibody

MBS7123634-5x01mL 5x0.1mL
EUR 1205

EGF Antibody

MBS7123635-005mL 0.05mL
EUR 190

EGF Antibody

MBS7123635-01mL 0.1mL
EUR 270

EGF Antibody

MBS7123635-5x01mL 5x0.1mL
EUR 1205

EGF antibody

10-E39A 500 ug
EUR 679.2
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2038 100 ul
EUR 468
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2176 100 ul
EUR 468
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2969 100 ug
EUR 218
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-2985 100 ug
EUR 218
Description: Mouse monoclonal EGF antibody

EGF antibody

10R-7766 500 ug
EUR 678
Description: Mouse monoclonal EGF antibody

EGF Antibody

35720 100ul
EUR 319

EGF Antibody

35720-100ul 100ul
EUR 302.4

EGF antibody

20C-CR1085GP 100 ug
EUR 109
Description: Goat polyclonal EGF antibody

EGF antibody

20R-1772 100 ug
EUR 807.6
Description: Rabbit polyclonal EGF antibody

EGF antibody

38447 100ul
EUR 439

EGF antibody

38447-100ul 100ul
EUR 302.4

EGF antibody

70R-EG001 50 ug
EUR 312
Description: Affinity purified Goat polyclonal EGF antibody

EGF antibody

70R-ER012 50 ug
EUR 312
Description: Affinity purified Rabbit polyclonal EGF antibody

EGF antibody

70R-5697 50 ug
EUR 467
Description: Rabbit polyclonal EGF antibody

EGF Antibody

49545 100ul
EUR 499

EGF Antibody

49545-100ul 100ul
EUR 399.6

EGF Antibody

49545-50ul 50ul
EUR 286.8

egf Antibody

CAC11577-100ug 100ug
EUR 314

egf Antibody

CAC11577-50ug 50ug
EUR 199.2

EGF Antibody

5022-100 each
EUR 379.2

EGF Antibody

5022-30T each
EUR 175.2

EGF Antibody

5023R-100 each
EUR 379.2

EGF Antibody

5023R-30T each
EUR 175.2

In the present day, using synthetic intelligence for supporting this transition exhibits actual limitations in its implementation in operational follow, each on the stage of affected person care, but in addition within the basic each day lifetime of the well being skilled, due to the medico-legal imperatives induced by the guarantees of the ‘5P medication’.

On this paper, we suggest to fill this hole by introducing an authentic synthetic intelligence platform, named Maxwell, which follows an unsupervised studying method consistent with the medico-legal imperatives of the ‘5P medication’. We describe the useful platform traits and illustrate them by two examples of clustering in genomics and magnetic resonance imaging.